Older, high-risk patients can safely defer percutaneous coronary intervention until after aortic valve replacement

Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) had comparable outcomes regardless of whether they underwent percutaneous coronary intervention (PCI) before TAVR, according to findings from the PRO-TAVI study presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup